These medications belong to the GLP-1 receptor agonist class and require weekly self-administered injections just under the skin
But GLP-1-receptor agonists such as liraglutide reduce cerebrospinal fluid secretion and have already proved effective in treating idiopathic intracranial hypertension (IIH)
Heres what it can do: Supports gut health BPC-157 helps strengthen the stomach lining and has been shown to protect against ulcers, acid reflux, and leaky gut
Monitoring of L-Carnitine levels may be necessary to ensure therapeutic effectiveness and to adjust dosing as needed
The drugs, including semaglutide (Ozempic, Wegovy and Rybelsus), tirzepatide (Mounjaro and Zepbound) and retatrutide (still in clinical trials), are used to treat both diabetes and obesity
Hakim takes a whole-person approach that includes micronutrient testing, gut health analysis, hormone balancing, and targeted supplementation